Follow
Devin Dersh
Devin Dersh
Verified email at pennmedicine.upenn.edu
Title
Cited by
Cited by
Year
GRP94 in ER quality control and stress responses
D Eletto, D Dersh, Y Argon
Seminars in cell & developmental biology 21 (5), 479-485, 2010
2612010
Protein disulfide isomerase A6 controls the decay of IRE1α signaling via disulfide-dependent association
D Eletto, D Eletto, D Dersh, T Gidalevitz, Y Argon
Molecular cell 53 (4), 562-576, 2014
2422014
A few good peptides: MHC class I-based cancer immunosurveillance and immunoevasion
D Dersh, J Hollý, JW Yewdell
Nature Reviews Immunology 21 (2), 116-128, 2021
1642021
Decoding mRNA translatability and stability from the 5′ UTR
L Jia, Y Mao, Q Ji, D Dersh, JW Yewdell, SB Qian
Nature Structural & Molecular Biology 27 (9), 814-821, 2020
1242020
Ribosomal proteins regulate MHC class I peptide generation for immunosurveillance
J Wei, RJ Kishton, M Angel, CS Conn, N Dalla-Venezia, V Marcel, ...
Molecular cell 73 (6), 1162-1173. e5, 2019
932019
Genome-wide Screens Identify Lineage-and Tumor-Specific Genes Modulating MHC-I-and MHC-II-Restricted Immunosurveillance of Human Lymphomas
D Dersh, JD Phelan, ME Gumina, B Wang, JH Arbuckle, J Holly, ...
Immunity 54 (1), 116-131. e10, 2021
822021
Stress and aging induce distinct polyQ protein aggregation states
LEM Mazzeo, D Dersh, M Boccitto, RG Kalb, T Lamitina
Proceedings of the National Academy of Sciences 109 (26), 10587-10592, 2012
702012
Tay–Sachs disease mutations in HEXA target the α chain of hexosaminidase A to endoplasmic reticulum–associated degradation
D Dersh, Y Iwamoto, Y Argon
Molecular biology of the cell 27 (24), 3813-3827, 2016
532016
Interferon inducible pseudouridine modification in human mRNA by quantitative nanopore profiling
S Huang, W Zhang, CD Katanski, D Dersh, Q Dai, K Lolans, J Yewdell, ...
Genome Biology 22 (1), 1-14, 2021
512021
Peptide Channeling: The Key to MHC Class I Immunosurveillance?
JW Yewdell, D Dersh, R Fåhraeus
Trends in Cell Biology, 2019
482019
Varied role of ubiquitylation in generating MHC class I peptide ligands
J Wei, D Zanker, AR Di Carluccio, MG Smelkinson, K Takeda, ...
The Journal of Immunology 198 (10), 3835-3845, 2017
452017
Limitation of individual folding resources in the ER leads to outcomes distinct from the unfolded protein response
D Eletto, A Maganty, D Eletto, D Dersh, C Makarewich, C Biswas, ...
J Cell Sci 125 (20), 4865-4875, 2012
412012
OS-9 facilitates turnover of nonnative GRP94 marked by hyperglycosylation
D Dersh, SM Jones, D Eletto, JC Christianson, Y Argon
Molecular biology of the cell 25 (15), 2220-2234, 2014
372014
A SIINFEKL-based system to measure MHC class I antigen presentation efficiency and kinetics
D Dersh, JW Yewdell, J Wei
Antigen Processing: Methods and Protocols, 109-122, 2019
192019
Long interleukin-22 binding protein isoform-1 is an intracellular activator of the unfolded protein response
P Gómez-Fernández, A Urtasun, AW Paton, JC Paton, F Borrego, D Dersh, ...
Frontiers in immunology 9, 2934, 2018
152018
Immune MAL2-practice: breast cancer immunoevasion via MHC class I degradation
D Dersh, JW Yewdell
The Journal of Clinical Investigation 131 (1), 2021
102021
I’ve got algorithm: predicting tumor and autoimmune peptide targets for CD8+ T cells
D Dersh, JW Yewdell
The Journal of clinical investigation 126 (12), 4399-4401, 2016
82016
Preventing Parkinson’s pathology
ME DeSantis, D Dersh
Disease models & mechanisms 3 (7-8), 399-400, 2010
52010
Author Correction: A few good peptides: MHC class I-based cancer immunosurveillance and immunoevasion
D Dersh, J Hollý, JW Yewdell
Nature Reviews Immunology 20 (10), 644-644, 2020
42020
Decoupling peptide binding from T cell receptor recognition with engineered chimeric MHC-I molecules
GF Papadaki, O Ani, TJ Florio, MC Young, JN Danon, Y Sun, D Dersh, ...
Frontiers in Immunology 14, 1116906, 2023
22023
The system can't perform the operation now. Try again later.
Articles 1–20